A research team drawn from Sweden, Germany, Italy and France has created the most complete ‘molecular film’ to date of a self ...

Researchers have used cryo-EM and computational tools to visualize ribozyme assembly, shedding light on life's most versatile ...

RNA modifications are increasingly recognized as clinically relevant biomarkers, revealing immune dysregulation in autoimmune disease, early oncogenic signaling, and RNA misprocessing in ...

Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...

Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities. Such abilities can include the ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

This valuable study presents an analysis of the gene regulatory networks that contribute to tumour heterogeneity and tumor plasticity in Ewing sarcoma, with key implications for other fusion-driven ...

A machine learning-based resource developed at St. Jude Children’s Research Hospital predicts which intrinsically disordered ...

AlidaBio today announced the launch of the EpiPlex™ Duo-Mod™ Service, a turnkey offering that maps and quantifies ...

The first study to examine the extent of European ancestry biases in gene maps reveals tens of thousands of genetic ...

MEMPHIS, Tenn. – December 3, 2025) Fusion oncoproteins arise when a gene fuses with another gene and acquires new abilities.

Life on Earth began simply. For billions of years, tiny microbes ruled the planet. Then, one day in deep time, something changed. Cells gained a nucleus, built inner compartments and learned to ...